SYRA HEALTH CORP. Cash and Cash Equivalents
SYRA HEALTH CORP. (SYRA) had Cash and Cash Equivalents of $2.12 million as of 2026-06-30, per its S-1 filed 2026-09-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-09-14
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $2.12M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $2.92M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $1.61M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $1.98M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $2.12M S-1 · filed 2026-09-14 |
| 2026-03-31 | $2.92M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $1.61M S-1 · filed 2026-09-14 |
| 2025-09-30 | $1.98M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $2.31M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $2.49M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $2.40M S-1 · filed 2026-09-14 |
| 2024-03-31 | $3.24M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $3.28M 10-K · filed 2025-03-11 |
| 2023-09-30 | $18.01K 10-Q · filed 2023-11-14 |
| 2022-12-31 | $3.34K 10-Q · filed 2023-11-14 |